Research Paper Volume 13, Issue 14 pp 18993—19012

A network pharmacology approach to uncover the key ingredients in Ginkgo Folium and their anti-Alzheimer’s disease mechanisms

Targets of GF against AD in control and AD groups of GEO dataset. (A–C) Entorhinal cortex, n = 39 in each group. (D, E) Hippocampus, n = 66 in healthy control, n = 74 in the AD patients. (F–L) Temporal cortex, n = 39 in healthy control, n = 52 in the AD patients. Values are presented as mean ± standard errors mean (SEM).

Figure 5. Targets of GF against AD in control and AD groups of GEO dataset. (AC) Entorhinal cortex, n = 39 in each group. (D, E) Hippocampus, n = 66 in healthy control, n = 74 in the AD patients. (FL) Temporal cortex, n = 39 in healthy control, n = 52 in the AD patients. Values are presented as mean ± standard errors mean (SEM).